4/A//SEC Filing
AKER HAZEL M 4/A
Accession 0001209191-20-044355
CIK 0001260990other
Filed
Jul 30, 8:00 PM ET
Accepted
Jul 31, 9:00 PM ET
Size
5.7 KB
Accession
0001209191-20-044355
Insider Transaction Report
Form 4/AAmended
AKER HAZEL M
General Counsel
Transactions
- Award
Stock Option
2020-03-17+11,080→ 11,080 totalExercise: $3.33Exp: 2030-03-17→ Common Stock (11,080 underlying)
Footnotes (2)
- [F1]The original Form 4 reported the acquisition of the Stock Options in the "D" column of Column 5. This amendment is being filed to correctly report the acquisition of the Stock Options in the "A" column of Column 5.
- [F2]Fully vested on grant date.
Documents
Issuer
Oncternal Therapeutics, Inc.
CIK 0001260990
Entity typeother
Related Parties
1- filerCIK 0001265783
Filing Metadata
- Form type
- 4/A
- Filed
- Jul 30, 8:00 PM ET
- Accepted
- Jul 31, 9:00 PM ET
- Size
- 5.7 KB